A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.

Y. Levin,E. Kochba,Georgi Shukarev,Sarah Rusch,Guillermo Herrera-Taracena,P. van Damme
DOI: https://doi.org/10.1016/j.vaccine.2016.09.008
IF: 4.169
2016-10-17
Vaccine
Abstract:
What problem does this paper attempt to address?